MedTrace Logo

Getting SMART for Pediatric Epilepsy

NCT05439876 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 147

Last updated 2025-08-29

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the effect of melatonin for improving sleep in pediatric epilepsy.

Conditions

  • Epilepsy in Children

Interventions

DRUG

Melatonin

Melatonin 2 mg daily for 4 weeks

DRUG

Placebo

Placebo daily for 4 weeks

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Wang-Tso Lee · National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-18
Primary Completion
2025-01-03
Completion
2025-01-03

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05439876 on ClinicalTrials.gov